Rezultaty - Ruben Rizzi

Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron era od Shanti Pather, Alexander Muik, Ruben Rizzi, Federico Mensa

Connect to this object online.

Developing variant-adapted COVID-19 vaccines to improve protection against Omicron and other recent variants: a plain language summary od Shanti Pather, Alexander Muik, Ruben Rizzi, Federico Mensa

Connect to this object online.

Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data od Frank van den Ouweland, Nicola Charpentier, Özlem Türeci, Ruben Rizzi, Federico J. Mensa, Claudia Lindemann, Shanti Pather

Connect to this object online.